Dociparstat sodium

DB16481InvestigationalSmall molecule

Dociparstat sodium: Overview.

Mechanism: Dociparstat sodium is derived from heparin which, like heparin, alters the activities of the CXCL12/CXCR4 axis and inhibits the interactions of proteins including P-selectin, high mobility group box 1, Platelet Factor 4, and human leukocyte elastase.
Curator reviewed
Also known as: 2,3-o-Desulfated heparin (12000 da)
Code names: GM-1892

Resolves to

Compound

Targets

What you can answer from here — as of July 08, 2026

6Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

5Clinical trialsPhase, status and sponsor resolved per trial

9+ReferencesStructured and connected to the statements they support

Which drugs share a target with Dociparstat sodium, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.